Drawing for ADALID

USPTO serial 79460554

ADALID

Reviewed by CopyMark Law Group

Status 640Office Action
Filing date
Status date
Registration date
—
Examiner
SMITH, BRENDAN K
Law office
TMEG LAW OFFICE 108

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 640: Status 640 means the examining attorney has prepared a non-final Office Action but it has not been mailed or e-mailed yet. The action should appear in TSDR soon, and a response deadline will start once it is issued.

Need help with ADALID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and chemical compounds for use in the biotechnological, cosmetic and pharmaceutical industry; chemicals and chemical compounds for use in scientific research; lipids and lipid-polymer conjugates for use in research and industry; molecules and lipid nanoparticles for use in biological research and biotechnological, cosmetic and pharmaceutical research and development and industryACTIVE—
005Chemical preparations for pharmaceutical purposes; nanoparticles for medical use and medical research; nanoparticles for use in drug delivery and for pharmaceutical use; lipid nanoparticles; drug delivery agentsACTIVE—
009Scientific research and laboratory apparatus, educational apparatus and simulators; scientific research and laboratory apparatus, namely lipid nanoparticles assembly instrumentation; scientific research and laboratory apparatus and equipment for producing lipid nanoparticles for scientific, pharmaceutical and medical research use, in the fields of life sciences, biotechnology, nanoparticles, biologics, gene therapy, nanoparticle drug delivery, and nanoparticle drug development, in particular precision mixing apparatus comprised of pumps, valves and microfluidic devices, computer hardware, flat panel display screens, and operating software; computer software for use in the field of biological, medical, biomedical and pharmacological research and development and in the field of pharmaceuticals and cosmetics manufacturing; databases for use in biological, medical, biomedical and pharmacological research and development and in the field of pharmaceuticals and cosmetics manufacturing; computer softwareACTIVE—
040Custom manufacture of pharmaceuticals and drug delivery systems; custom manufacture of cosmetics and ingredients for cosmetic preparations; custom manufacture of lipid nanoparticlesACTIVE—
042Scientific research; biotechnological research; chemical research; biological research; medical, biomedical and pharmacological research services; cosmetic research; research and development services; research and development of new products for others; research and development of pharmaceuticals; research in the field of gene therapy; research and development in the field of lipid nanoparticles; research and development in the field of polymeric nanoparticles; research and development in the field of polymers; research and development in the field of lipids; research and development in the field of drug delivery systems; laboratory services; research in instrumentation; design and development of new products, namely scientific and laboratory instruments and equipment; rental of science and technology equipment; software development, programming and implementation; machine learning engineering and data science services; consultancy relating to pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals; consultancy and advisory services relating to research of lipid nanoparticles; consultancy pertaining to pharmacologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 16, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2026DOCKASSIGNED TO EXAMINER—
Oct 21, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 21, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 15, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance